Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous sodium selenite and procalcitonin-guided therapy in severe sepsis and septic shock
2007-004333-42Phase 3Completed
- Sponsor
- Friedrich Schiller University Jena
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sodium selenite in sepsis and septic shock (2 arms), sponsored by Friedrich Schiller University Jena. Primary endpoint: 28-day total mortality. Started Mar 2008; status: completed.
02
Drugs
sodium selenite
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on 2007-004333-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004333-42.